Ensign Peak Advisors »

Rapport Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.8M 194k 29.70
2025-06-30 $2.2M 194k 11.37
2025-03-31 $1.9M 194k 10.03